Cargando…
DFT study on the structural and chemical properties of Janus kinase inhibitor drug Baricitinib
Baricitinib is a small molecule used to treat moderate to severe rheumatoid arthritis (RA) in adults. It is an inhibitor of Janus kinase 1 and 2 (JAK1 and JAK2). It has also been repurposed as a potential treatment for Covid 19. The current study has been carried out to understand the structural and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395141/ https://www.ncbi.nlm.nih.gov/pubmed/36032699 http://dx.doi.org/10.1016/j.matpr.2022.04.868 |